Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Open accessAbstract
MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in regulating gene expression. The majority of miRNAs are transcribed from DNA sequences into primary miRNAs and processed into precursor miRNAs, and finally mature miRNAs. In most cases, miRNAs interact with the 3' untranslated region (3' UTR) of target mRNAs to induce mRNA degradation and translational repression. However, interaction of miRNAs with other regions, including the 5' UTR, coding sequence, and gene promoters, have also been reported. Under certain conditions, miRNAs can also activate translation or regulate transcription. The interaction of miRNAs with their target genes is dynamic and dependent on many factors, such as subcellular location of miRNAs, the abundancy of miRNAs and target mRNAs, and the affinity of miRNA-mRNA interactions. miRNAs can be secreted into extracellular fluids and transported to target cells via vesicles, such as exosomes, or by binding to proteins, including Argonautes. Extracellular miRNAs function as chemical messengers to mediate cell-cell communication. In this review, we provide an update on canonical and non-canonical miRNA biogenesis pathways and various mechanisms underlying miRNA-mediated gene regulations. We also summarize the current knowledge of the dynamics of miRNA action and of the secretion, transfer, and uptake of extracellular miRNAs.
AI snapshot
Written from the paper’s full text.
TL;DR
This review summarizes microRNA biogenesis, mechanisms of action, dynamic subcellular regulation, and extracellular circulation. It highlights miRNAs as both gene regulators and intercellular signals while noting unresolved questions about nuclear function, translational activation, and secretion/uptake.
Key findings
- Canonical miRNA biogenesis involves pri-miRNA processing by Drosha/DGCR8, export by XPO5/RanGTP, Dicer cleavage into a mature duplex, and loading of the 5p or 3p strand into AGO1–4; non-canonical pathways include Drosha/DGCR8-independent mirtrons and m7G-capped pre-miRNAs, and Dicer-independent AGO2-dependent processing.
- Most miRNAs bind 3′ UTR miRNA response elements to induce translational repression and mRNA deadenylation, decapping, and degradation via GW182, PAN2/3, CCR4-NOT, DCP2, and XRN1; binding to 5′ UTR/coding regions can silence, promoter binding can induce transcription, and activation occurs under specific conditions such as serum starvation, cell cycle arrest, oocytes, and amino acid starvation.
- miRNA action is dynamic: miRISC localizes to rER, P-bodies, stress granules, endosomes, multivesicular bodies, mitochondria, and the nucleus; average polysome occupancy is below 40%, and FANTOM5 data indicate that the top five expressed miRNAs represent on average ~50% of the miRNA pool in a given human cell type, with about half cell-type enriched and one quarter broadly expressed.
- Extracellular miRNAs are highly stable, resisting room-temperature degradation for up to 4 days and conditions such as boiling, freeze-thaw cycles, and high or low pH; they circulate in vesicles or bound to proteins such as AGO2, HDL, and NPM1, and can act as autocrine, paracrine, or endocrine signals, including via Toll-like receptors.
Methods
- Narrative review; no primary experimental data, systematic search strategy, or sample size is reported.
- The main analysis is a thematic synthesis of published literature on canonical and non-canonical biogenesis, miRNA-mediated gene regulation, subcellular dynamics, and extracellular miRNA circulation.
- Data/sample: not applicable; the paper synthesizes prior studies and includes proposed models in figures.
Limitations
- The paper states that understanding of when and how miRNAs regulate transcription is limited, conditions for translational activation need further exploration, and mechanisms of extracellular miRNA secretion and uptake are not well understood.
- The paper notes that many studies use in vitro transfection into immortalized or cancer cell lines, which may not reflect endogenous miRNA functions in vivo, and that chemical tags on miRNAs could affect miRNA:MRE or AGO:miRNA interactions.
- Evident from the text: as a narrative review, it does not systematically assess evidence quality or quantify effect sizes across the cited literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 127 cited sources checked · 0 supported · 0 flagged
- Premisecitation
In serum starved cells, AGO2 and FXR1 were associated with AU-rich elements at the 3' UTR to activate translation.
“In serum starved cells, AGO2 and another protein related to the miRNA-protein complex (microRNPs), Fragile-x-mental retardation related protein 1 (FXR1), were associated with AU-rich elements (AREs) at 3′ UTR to activate translation (55).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Vasudevan, 2007, AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2, Cell source
Not checked in the free run.
- Premisecitation
In most cases, miRNAs interact with the 3' UTR of target mRNAs to induce mRNA degradation and translational repression.
“In most cases, miRNAs interact with the 3′ untranslated region (3′ UTR) of target mRNAs to induce mRNA degradation and translational repression.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Ha, 2014, Regulation of microRNA biogenesis, Nat Rev Mol Cell Biol. source
Not checked in the free run.
- Premisecitation
Extracellular miRNAs function as chemical messengers to mediate cell-cell communication.
“Extracellular miRNAs function as chemical messengers to mediate cell-cell communication.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [21] Hayes, 2014, MicroRNAs in cancer: biomarkers, functions and therapy, Trends Mol Med. source
Not checked in the free run.
- cites [22] Wang, 2016, MicroRNA as Biomarkers and Diagnostics, J Cell Physiol. source
Not checked in the free run.
- cites [23] Huang, 2017, MicroRNAs: biomarkers, diagnostics, and therapeutics, Methods Mol Biol. source
Not checked in the free run.
- Premisecitation
In the canonical pathway, pri-miRNAs are processed into pre-miRNAs by the microprocessor complex consisting of DGCR8 and Drosha.
“In this pathway, pri-miRNAs are transcribed from their genes and then processed into pre-miRNAs by the microprocessor complex, consisting of an RNA binding protein DiGeorge Syndrome Critical Region 8 (DGCR8) and a ribonuclease III enzyme, Drosha (27).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Denli, 2004, Processing of primary microRNAs by the Microprocessor complex, Nature source
Not checked in the free run.
- Premisecitation
miRNA interaction with promoter region has been reported to induce transcription.
“while miRNA interaction with promoter region has been reported to induce transcription (45).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Dharap, 2013, MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene, PLoS ONE source
Not checked in the free run.
- Premisecitation
The minimal miRNA-induced silencing complex (miRISC) consists of the guide strand and AGO.
“The minimal miRNA-induced silencing complex (miRISC) consists of the guide strand and AGO (46).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Kawamata, 2010, Making RISC, Trends Biochem Sci. source
Not checked in the free run.
- Premisecitation
miRNA-mediated activation of translation involves AGO2 and FXR1 instead of GW182.
“The miRNA-mediated activation of translation involves AGO2 and FXR1 instead of GW182 (56).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Truesdell, 2012, MicroRNA-mediated mRNA translation activation in quiescent cells and oocytes involves recruitment of a nuclear microRNP, Sci Rep. source
Not checked in the free run.
- Premisecitation
The selection of the 5p or 3p strand is based in part on the thermodynamic stability at the 5' ends of the miRNA duplex or a 5' U at nucleotide position 1.
“The selection of the 5p or 3p strand is based in part on the thermodynamic stability at the 5′ ends of the miRNA duplex or a 5′ U at nucleotide position 1 (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Khvorova, 2003, Functional siRNAs and miRNAs exhibit strand bias, Cell source
Not checked in the free run.
- Premisecitation
Both strands derived from the mature miRNA duplex can be loaded into the Argonaute family of proteins (AGO1-4 in humans) in an ATP-dependent manner.
“Both strands derived from the mature miRNA duplex can be loaded into the Argonaute (AGO) family of proteins (AGO1-4 in humans) in an ATP-dependent manner (32).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Yoda, 2010, ATP-dependent human RISC assembly pathways, Nat Struct Mol Biol. source
Not checked in the free run.
- Premisecitation
miRNAs can interact with other regions including the 5' UTR, coding sequence, and gene promoters.
“However, interaction of miRNAs with other regions, including the 5′ UTR, coding sequence, and gene promoters, have also been reported.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Broughton, 2016, Pairing beyond the Seed Supports MicroRNA Targeting Specificity, Mol Cell. source
Not checked in the free run.
- Premisecitation
In many cases, a functional miRNA:MRE interaction occurs via the 5' seed region (nucleotides 2-8).
“In many cases, a functional miRNA:MRE interaction occurs via the 5' seed region (nucleotides 2–8) (42, 51).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
miRNA biogenesis starts with the processing of RNA polymerase II/III transcripts post- or co-transcriptionally.
“miRNA biogenesis starts with the processing of RNA polymerase II/III transcripts post- or co-transcriptionally (14).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Ha, 2014, Regulation of microRNA biogenesis, Nat Rev Mol Cell Biol. source
Not checked in the free run.
- Premisecitation
Target mRNA poly(A)-deadenylation is initiated by PAN2/3 and completed by the CCR4-NOT complex.
“Target mRNA poly(A)-deadenylation is initiated by PAN2/3 and completed by the CCR4-NOT complex.”
Quote in the paperNot a substantial claim - Premisenone given
Non-canonical miRNA biogenesis can be grouped into Drosha/DGCR8-independent and Dicer-independent pathways.
“In general, the non-canonical miRNA biogenesis can be grouped into Drosha/DGCR8-independent and Dicer-independent pathways.”
Quote in the paperNot a substantial claim - Premisecitation
For any given miRNA, the proportion of AGO-loaded 5p or 3p strand varies greatly depending on the cell type or cellular environment, ranging from near equal proportions to predominantly one or the other.
“For any given miRNA, the proportion of AGO-loaded 5p or 3p strand varies greatly depending on the cell type or cellular environment, ranging from near equal proportions to predominantly one or the other (33).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Meijer, 2014, Regulation of miRNA strand selection: follow the leader?, Biochem Soc Trans. source
Not checked in the free run.
- Premisenone given
The canonical biogenesis pathway is the dominant pathway by which miRNAs are processed.
“The canonical biogenesis pathway is the dominant pathway by which miRNAs are processed.”
Quote in the paperNot a substantial claim - Premisecitation
miRNAs can be secreted into extracellular fluids and transported to target cells via vesicles such as exosomes or by binding to proteins including Argonautes.
“miRNAs can be secreted into extracellular fluids and transported to target cells via vesicles, such as exosomes, or by binding to proteins, including Argonautes.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [116] Iftikhar, 2016, Evidence and potential in vivo functions for biofluid miRNAs: from expression profiling to functional testing: potential roles of extracellular miRNAs as indicators of physiological change and as agents of intercellular information exchange, Bioessays source
Not checked in the free run.
- cites [120] Gallo, 2012, The majority of microRNAs detectable in serum and saliva is concentrated in exosomes, PLoS ONE source
Not checked in the free run.
- cites [125] Turchinovich, 2011, Characterization of extracellular circulating microRNA, Nucleic Acids Res. source
Not checked in the free run.
- Premisecitation
Most studies show that miRNAs bind to a specific sequence at the 3' UTR of their target mRNAs to induce translational repression and mRNA deadenylation and decapping.
“Most studies to date have shown that miRNAs bind to a specific sequence at the 3′ UTR of their target mRNAs to induce translational repression and mRNA deadenylation and decapping (40, 41).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [40] Huntzinger, 2011, Gene silencing by microRNAs: contributions of translational repression and mRNA decay, Nat Rev Genet. source
Not checked in the free run.
- cites [41] Ipsaro, 2015, From guide to target: molecular insights into eukaryotic RNA-interference machinery, Nat Struct Mol Biol. source
Not checked in the free run.
- Premisecitation
In animal cells, the majority of miRNA:MRE interactions are not fully complementary.
“In animal cells, the majority of miRNA:MRE interactions are not fully complementary (50).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Jonas, 2015, Towards a molecular understanding of microRNA-mediated gene silencing, Nat Rev Genet. source
Not checked in the free run.
- Premisecitation
The binding of miRNAs to 5' UTR and coding regions has silencing effects on gene expression.
“The binding of miRNAs to 5′ UTR and coding regions have silencing effects on gene expression (43, 44) while miRNA interaction with promoter region has been reported to induce transcription (45).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [43] Forman, 2008, A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence, Proc Natl Acad Sci USA. source
Not checked in the free run.
- cites [44] Zhang, 2018, Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5′ UTR of RUNX3, Oncol Lett. source
Not checked in the free run.
- Premisecitation
miRNA binding sites have also been detected in other mRNA regions including the 5' UTR and coding sequence, as well as within promoter regions.
“miRNA binding sites have also been detected in other mRNA regions including the 5′ UTR and coding sequence, as well as within promoter regions (42).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Xu, 2014, Identifying microRNA targets in different gene regions, BMC Bioinformatics source
Not checked in the free run.
- Premisecitation
The degree of MRE complementarity determines whether there is AGO2-dependent slicing of target mRNA or miRISC-mediated translational inhibition and target mRNA decay.
“The degree of MRE complementarity determines whether there is AGO2-dependent slicing of target mRNA or miRISC-mediated translational inhibition and target mRNA decay (47).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Jo, 2015, Human Argonaute 2 Has diverse reaction pathways on Target RNAs, Mol Cell. source
Not checked in the free run.
- Premisecitation
Aberrant expression of miRNAs is associated with many human diseases.
“Aberrant expression of miRNAs is associated with many human diseases (19, 20).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
P-bodies are cytoplasmic foci depleted of ribosomes and enriched with enzymatic mRNA degradation machinery such as mRNA decapping proteins, the CCR4-NOT complex, XRN1, and GW182 family proteins.
“They are cytoplasmic foci depleted of ribosomes (79) and enriched with enzymatic mRNA degradation machinery, such as mRNA decapping proteins, the CCR4-NOT complex, XRN1, and GW182 family proteins (78).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Low molecular weight miRISC can interact with mRNAs within the nucleus and induce nuclear mRNA degradation.
“It has been reported that low molecular weight miRISC can interact with mRNAs within the nucleus and induce nuclear mRNA degradation, although the mechanism behind this is unclear (59, 61, 63).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [59] Nishi, 2013, Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus, RNA source
Not checked in the free run.
- cites [61] Pitchiaya, 2017, Resolving subcellular miRNA trafficking and turnover at single-molecule resolution, Cell Rep. source
Not checked in the free run.
- cites [63] Bottini, 2017, Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq, Nat Commun. source
Not checked in the free run.
- Premisecitation
For any given human cell type, the top five expressed miRNAs represent on average approximately 50% of the overall miRNA pool.
“Recently, the work by the Functional Annotation of the Mammalian Genome (FANTOM5) consortium found that for any given human cell type, the top five expressed miRNAs represent on average ~50% of the overall miRNA pool (13).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] de Rie, 2017, An integrated expression atlas of miRNAs and their promoters in human and mouse, Nat Biotechnol. source
Not checked in the free run.
- Premisecitation
miRISC and target mRNA localize in multiple subcellular compartments including rough endoplasmic reticulum, P-bodies, stress granules, trans-Golgi network, early/late endosomes, multivesicular bodies, lysosomes, mitochondria, and the nucleus.
“miRISC and target mRNA have been observed to localize in multiple subcellular compartments including rough endoplasmic reticulum (rER) (70), processing (P)-bodies (71), stress granules (SG) (72), the trans-Golgi network (TGN), early/late endosomes (73), multivesicular bodies (MVB) (74), lysosomes (74), mitochondria (75, 76), and the nucleus (66, 77) (Figure 2).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [70] Barman, 2015, mRNA targeting to endoplasmic reticulum precedes ago protein interaction and microRNA (miRNA)-mediated translation repression in mammalian cells, J Biol Chem. source
Not checked in the free run.
- cites [71] Nishi, 2015, Control of the localization and function of a miRNA silencing component TNRC6A by Argonaute protein, Nucleic Acids Res source
Not checked in the free run.
- cites [72] Detzer, 2011, Cell stress is related to re-localization of Argonaute 2 and to decreased RNA interference in human cells, Nucleic Acids Res. source
Not checked in the free run.
- Premisecitation
Synergistic effects of miRNAs have been shown to be important for biological processes such as neurogenesis and human embryonic stem cell pluripotency and differentiation.
“Synergistic effects of miRNAs have been shown to be important for biological processes, such as neurogenesis (104) and human embryonic stem cell pluripotency and differentiation (105).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [104] Pons-Espinal, 2017, Synergic functions of miRNAs determine neuronal fate of adult neural stem cells, Stem Cell Rep. source
Not checked in the free run.
- cites [105] Sahu, 2018, Deciphering synergistic regulatory networks of microRNAs in hESCs and fibroblasts, Int J Biol Macromol. source
Not checked in the free run.
- Premisecitation
Low expression but functional miRNA may synergistically increase RNAi activity on a subset of target mRNAs, thereby effectively enhancing the concentration of cognate miRNAs for specific mRNAs.
“In this way, low expression but functional miRNA may synergistically increase RNAi activity on a subset of target mRNAs, thereby effectively enhancing the concentration of cognate miRNAs for specific mRNAs (101, 102).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [101] Li, 2014, Mirsynergy: detecting synergistic miRNA regulatory modules by overlapping neighbourhood expansion, Bioinformatics source
Not checked in the free run.
- cites [102] Lemus-Diaz, 2017, Dissecting miRNA gene repression on single cell level with an advanced fluorescent reporter system, Sci Rep. source
Not checked in the free run.
- Premisecitation
mRNAs with higher affinity MREs generally show greater sensitivity to miRNA-mediated post-transcriptional repression.
“On the other hand, mRNAs with higher affinity MREs generally show greater sensitivity to miRNA-mediated post-transcriptional repression (84, 94).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [84] Molotski, 2012, Differential association of microRNAs with polysomes reflects distinct strengths of interactions with their mRNA targets, RNA source
Not checked in the free run.
- cites [94] Denzler, 2016, Impact of MicroRNA levels, target-site complementarity, and cooperativity on competing endogenous RNA-regulated gene expression, Mol Cell source
Not checked in the free run.
- Premisecitation
The strongest predictor of protein level for any given gene is the rate of translation, followed by mRNA levels.
“Accordingly, the strongest predictor of protein level for any given gene is the rate of translation, followed by mRNA levels (93).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93] Schwanhäusser, 2011, Global quantification of mammalian gene expression control, Nature source
Not checked in the free run.
- Premisecitation
P-bodies form in an RNA-dependent manner as a consequence of RNAi and RNA degradation.
“Furthermore, P-bodies form in an RNA-dependent manner as a consequence of RNAi and RNA degradation (80).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Eulalio, 2007, P-body formation is a consequence, not the cause, of RNA-mediated gene silencing, Mol Cell Biol. source
Not checked in the free run.
- Premisecitation
Modulation of MRE load with competing endogenous RNAs such as circular RNAs can sequester miRISC from target mRNA, leading to derepression of target mRNA.
“In this way, modulation of MRE load with competing endogenous RNAs (ceRNAs), such as with circular RNAs (circRNAs) (96), can act to sequester miRISC from target mRNA, leading to derepression of target mRNA (97).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Disruption of nesprin-1 activity through mutations and RNAi significantly decreased miRNA suppression of target mRNA and P-body formation.
“Disruption of nesprin-1 activity through mutations and RNAi significantly decreased miRNA suppression of target mRNA and P-body formation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] Rajgor, 2014, Mammalian microtubule P-body dynamics are mediated by nesprin-1, J Cell Biol. source
Not checked in the free run.
- Premisecitation
Human AGO2 shuttles between the nucleus and cytoplasm via its interaction with TNRC6A through Importin-8 or Exportin-1.
“Through Importin-8 or Exportin-1, human AGO2 shuttles between the nucleus and cytoplasm via its interaction with TNRC6A (a GW182 family protein) which contains a nuclear localization and export signal (59).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] Nishi, 2013, Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus, RNA source
Not checked in the free run.
- Premisecitation
Low miRNA levels can be compensated for when target mRNA levels are high by stimulating increased loading of cognate miRNA into AGO, thereby improving RNAi activity.
“Inversely, low miRNA levels can be compensated for, when target mRNA levels are high, by stimulating increased loading of cognate miRNA into AGO, thereby improving RNAi activity (103).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Bose, 2016, Target-dependent biogenesis of cognate microRNAs in human cells, Nat Commun. source
Not checked in the free run.
- Premisecitation
Nuclear miR-522 interacts with a DNA cruciform structure within the promoter of CYP2E1 and suppresses its transcription.
“A more recent study by Miao et al. (66) found nuclear miR-522 interacting with a DNA cruciform structure (a stem-loop on sense and antisense DNA strands) within the promoter of CYP2E1 and suppressing its transcription (66).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Miao, 2016, A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1, Biochim Biophys Acta source
Not checked in the free run.
- Premisecitation
miRNAs may play key roles in the post-transcriptional reduction of expression noise.
“Intriguingly, miRNA do not solely, or maybe even predominantly, function as target-specific regulators but may play key roles in the post-transcriptional reduction of expression noise (89, 90).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
miRNAs enter recipient cells by endocytosis and micropinocytosis.
“Indeed, several studies have shown that miRNAs enter recipient cells by endocytosis and micropinocytosis (141, 142).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [141] Xu, 2013, Synaptosomes secrete and uptake functionally active microRNAs via exocytosis and endocytosis pathways, J Neurochem. source
Not checked in the free run.
- cites [142] Tian, 2014, Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery, J Biol Chem. source
Not checked in the free run.
- Interpretationnone given
The mechanisms of extracellular miRNA uptake are not well understood.
“The mechanisms of extracellular miRNA uptake are not well understood.”
Quote in the paperNot a substantial claim - Premisecitation
Secretion of miRNAs via exosomes is regulated by signaling molecules such as interleukin-4 and docosahexaenoic acid.
“Secretion of miRNAs via exosomes have also been reported to be regulated by signaling molecules, such as interleukin-4 (IL4) (132) and Docosahexaenoic acid (DHA) (133).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [132] Yang, 2011, Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells, Mol Cancer source
Not checked in the free run.
- cites [133] Hannafon, 2015, Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA), Mol Cancer source
Not checked in the free run.
- Premisecitation
Extracellular miRNAs can exert biological functions in recipient cells to regulate their activity, thereby acting as intercellular signaling molecules.
“Many studies have also demonstrated that extracellular miRNAs can exert biological functions in recipient cells to regulate their activity, thereby acting as intercellular signaling molecules.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [134] Zhou, 2014, Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis, Cancer Cell source
Not checked in the free run.
- cites [135] Hu, 2018, Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function, Theranostics source
Not checked in the free run.
- cites [136] Sakha, 2016, Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma, Sci Rep. source
Not checked in the free run.
- Premisecitation
Extracellular miRNAs are highly stable, resisting degradation at room temperature for up to 4 days and in deleterious conditions such as boiling, multiple freeze-thaw cycles, and high or low pH.
“Contrary to cellular RNA species, extracellular miRNAs are highly stable, resisting degradation at room temperature for up to 4 days and in deleterious conditions such as boiling, multiple freeze-thaw cycles, and high or low pH (117, 124).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [117] Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res source
Not checked in the free run.
- cites [124] Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA. source
Not checked in the free run.
- Premisecitation
Other proteins found to bind extracellular miRNAs include high-density lipoprotein and nucleophosmin 1.
“Other proteins found to bind extracellular miRNAs include high-density lipoprotein (HDL) (126, 127) and nucleophosmin 1 (NPM1) (110, 118, 128).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [126] Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat Cell Biol. source
Not checked in the free run.
- cites [127] Tabet, 2014, HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells, Nat Commun. source
Not checked in the free run.
- cites [110] Wang, 2010, Export of microRNAs and microRNA-protective protein by mammalian cells, Nucleic Acids Res. source
Not checked in the free run.
- Interpretationreasoning
miRNAs may act as chemical messengers to regulate cell-cell communications.
“Thus, miRNAs may act as chemical messengers to regulate cell-cell communications.”
Quote in the paperSubstantial claim - Premisecitation
Many studies have detected extracellular/circulating miRNAs in biological fluids such as plasma, serum, cerebrospinal fluid, saliva, breast milk, urine, tears, colostrum, peritoneal fluid, bronchial lavage, seminal fluid, and ovarian follicular fluid.
“Many studies have detected extracellular/circulating miRNAs in biological fluids, such as plasma and serum (117, 118), cerebrospinal fluid (119), saliva (120), breast milk (121), urine, tears, colostrum, peritoneal fluid, bronchial lavage, seminal fluid (122), and ovarian follicular fluid (123).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [117] Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res source
Not checked in the free run.
- cites [118] Arroyo, 2011, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [119] Cogswell, 2008, Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways, J Alzheimers Dis. source
Not checked in the free run.
- Premisecitation
Vesicle-free miRNAs associated with HDL are taken up by HDL receptor and scavenger receptor BI (SR-BI) in the plasma membrane of target cells.
“Furthermore, vesicle-free miRNAs associated with HDL are taken up by HDL receptor and scavenger receptor BI (SR-BI) receptor in the plasma membrane of the target cells (126, 127).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [126] Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat Cell Biol. source
Not checked in the free run.
- cites [127] Tabet, 2014, HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells, Nat Commun. source
Not checked in the free run.
- Premisecitation
IL4-activated macrophages were found to secrete exosomes carrying oncogenic miRNAs to promote invasiveness of breast cancer cells.
“IL4-activated macrophages were found to secrete exosomes carrying oncogenic miRNAs to promote invasiveness of breast cancer cells (132).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] Yang, 2011, Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells, Mol Cancer source
Not checked in the free run.
- Premisecitation
Atheroprotective laminar shear stress induced the release of vesicle-free miR-126-3p and other miRNAs, as well as AGO2, from endothelial cells by activating VAMP3 and SNAP23.
“Recently, it was demonstrated that atheroprotective laminar shear stress induced the release of vesicle-free miR-126-3p and other miRNAs, as well as AGO2, from endothelial cells by activating vesicle-associated membrane protein 3 (VAMP3) and synaptosomal-associated protein 23 (SNAP23) (130).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [130] Zhu, 2017, VAMP3 and SNAP23 mediate the disturbed flow-induced endothelial microRNA secretion and smooth muscle hyperplasia, Proc Natl Acad Sci USA. source
Not checked in the free run.
- Premisecitation
In A549-P cells, endocytosis of exosomal miRNAs is mediated by caveolae- and lipid raft-dependent pathways.
“However, another study conducted in A549-P cells showed that endocytosis of exosomal miRNAs is mediated by caveolae- and lipid raft-dependent pathways (143).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [143] Wei, 2017, Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p, Mol Cancer source
Not checked in the free run.
- Premisecitation
miRNAs secreted from endothelium can regulate the activity of smooth muscle cells.
“This study also showed that miRNAs secreted from endothelium can regulate the activity of smooth muscle cells (130).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [130] Zhu, 2017, VAMP3 and SNAP23 mediate the disturbed flow-induced endothelial microRNA secretion and smooth muscle hyperplasia, Proc Natl Acad Sci USA. source
Not checked in the free run.
- Premisecitation
miR-342-3p and miR-1246 secreted from a highly metastatic human oral cancer cell line induce metastasis in a poorly metastatic cancer cell line.
“miRNAs, specifically miR-342–3p and miR-1246, secreted from a highly metastatic human oral cancer cell line, were found to induce metastasis in a poorly metastatic cancer cell line (136).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [136] Sakha, 2016, Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma, Sci Rep. source
Not checked in the free run.
- Interpretationnone given
miRNAs are involved in transcription.
“It is now clear that miRNAs are powerful gene regulators, and that they not only help control mRNA stability and translation but are also involved in transcription.”
Quote in the paperSubstantial claim - Interpretationreasoning
miRNAs have hormone-like activities.
“Therefore, miRNAs have hormone-like activities.”
Quote in the paperSubstantial claim - Interpretationnone given
miRNAs help control mRNA stability and translation.
“It is now clear that miRNAs are powerful gene regulators, and that they not only help control mRNA stability and translation but are also involved in transcription.”
Quote in the paperSubstantial claim - Premisecitation
miRNAs transfer between co-cultured cells via direct cell-cell contact and gap junctions.
“miRNAs have also been shown to transfer between co-cultured cells via direct cell-cell contact and gap junctions (144).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [144] Aucher, 2013, MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation, J Immunol. source
Not checked in the free run.
- Premisereasoning
Extracellular/circulating miRNAs play important roles in intercellular communication.
“It is now accepted that extracellular/circulating miRNAs can not only serve as biomarkers for diseases, but also play important roles in intercellular communication.”
Quote in the paperSubstantial claim - Interpretationreasoning
Extracellular miRNAs can interact with recipient cells via multiple mechanisms.
“While these studies suggest that extracellular miRNAs can interact with recipient cells via multiple mechanisms, the factors that determine the specificity of such interactions need to be investigated.”
Quote in the paperSubstantial claim - Interpretationnone given
Localization of miRISC components, levels of miRNAs and target mRNAs, and affinity of miRNA-mRNA interaction are important for efficient gene regulation.
“Moreover, their localization, together with the levels of miRNAs and target mRNAs, and the affinity of the miRNA-mRNA interaction, are important for efficient gene regulation.”
Quote in the paperSubstantial claim - Interpretationreasoning
Tags to the first and last miRNA nucleotides may affect miRNA functioning in unpredictable ways.
“The first and last miRNA nucleotides clamp the miRNA within AGO proteins, and thus tags to these regions may affect miRNA functioning in unpredictable ways.”
Quote in the paperNot a substantial claim- Rests on an assumption: The first and last miRNA nucleotides clamp the miRNA within AGO proteins.
- Interpretationcitation
Apart from Toll-like receptors, miRceptors remain to be identified.
“Although miRceptors have been proposed (137), apart from the Toll-like receptors, they remain to be identified.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [137] Fabbri, 2018, MicroRNAs and miRceptors: a new mechanism of action for intercellular communication, Philos Trans R Soc Lond B Biol Sci. source
Not checked in the free run.
- Premisenone given
miRNAs regulate the activity of host cells.
“miRNAs regulate the activity of host cells, and they are also secreted and transferred to recipient cells.”
Quote in the paperSubstantial claim - Premisenone given
Extracellular/circulating miRNAs can serve as biomarkers for diseases.
“It is now accepted that extracellular/circulating miRNAs can not only serve as biomarkers for diseases, but also play important roles in intercellular communication.”
Quote in the paperSubstantial claim - Premisecitation
Some miRNAs can interact with cell surface receptors, such as Toll-like receptors.
“Some miRNAs can even interact with cell surface receptors, such as Toll-like receptors.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [137] Fabbri, 2018, MicroRNAs and miRceptors: a new mechanism of action for intercellular communication, Philos Trans R Soc Lond B Biol Sci. source
Not checked in the free run.
- Premisecitation
Extracellular miRNAs are functionally active in recipient cells.
“Many studies have shown that extracellular miRNAs are functionally active in recipient cells.”
Quote in the paperSubstantial claim
- May combine two claims. 29
- Classified as probably not a substantial claim. 13
May combine two claims.
PremisecitationUnder certain conditions, miRNAs can activate translation or regulate transcription.
“Under certain conditions, miRNAs can also activate translation or regulate transcription.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Vasudevan, 2012, Posttranscriptional upregulation by microRNAs, Wiley Interdiscip Rev RNA source
Not checked in the free run.
May combine two claims.
PremisecitationThe formation of a silencing miRISC complex starts with the recruitment of the GW182 family of proteins by miRISC; GW182 provides the scaffolding needed to recruit other effector proteins such as the poly(A)-deadenylase complexes PAN2-PAN3 and CCR4-NOT following miRNA:target mRNA interaction.
“The formation of a silencing miRISC complex starts with the recruitment of the GW182 family of proteins by miRISC; GW182 provides the scaffolding needed to recruit other effector proteins (52), such as the poly(A)-deadenylase complexes PAN2-PAN3 and CCR4-NOT, following miRNA:target mRNA interaction (50, 53).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [52] Behm-Ansmant, 2006, mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes, Genes Dev. source
Not checked in the free run.
- cites [50] Jonas, 2015, Towards a molecular understanding of microRNA-mediated gene silencing, Nat Rev Genet. source
Not checked in the free run.
- cites [53] Christie, 2013, Structure of the PAN3 pseudokinase reveals the basis for interactions with the PAN2 deadenylase and the GW182 proteins, Mol Cell. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMirtrons are produced from the introns of mRNA during splicing.
“An example of such pre-miRNAs is mirtrons, which are produced from the introns of mRNA during splicing (35, 36).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [35] Ruby, 2007, Intronic microRNA precursors that bypass Drosha processing, Nature source
Not checked in the free run.
- cites [36] Babiarz, 2008, Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs, Genes Dev. source
Not checked in the free run.
May combine two claims.
PremisecitationDicer-independent miRNAs are processed by Drosha from endogenous short hairpin RNA transcripts and require AGO2 to complete their maturation within the cytoplasm.
“On the other hand, Dicer-independent miRNAs are processed by Drosha from endogenous short hairpin RNA (shRNA) transcripts (38). These pre-miRNAs require AGO2 to complete their maturation within the cytoplasm because they are of insufficient length to be Dicer-substrates (38).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Yang, 2010, Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis, Proc Natl Acad Sci USA. source
Not checked in the free run.
May combine two claims.
PremisecitationSeveral miRNAs including let-7 were found to be associated with AGO2 and FXR1 to activate translation during cell cycle arrest, but they inhibit translation in proliferating cells.
“Several miRNAs, including let-7, were found to be associated with AGO2 and FXR1 to activate translation during cell cycle arrest, but they inhibit translation in proliferating cells (55).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Vasudevan, 2007, AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationAbout half of all currently identified miRNAs are intragenic and processed mostly from introns and relatively few exons of protein coding genes, while the remaining are intergenic, transcribed independently of a host gene and regulated by their own promoters.
“About half of all currently identified miRNAs are intragenic and processed mostly from introns and relatively few exons of protein coding genes, while the remaining are intergenic, transcribed independently of a host gene and regulated by their own promoters (13, 24).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe interaction of miRNAs with their target genes is dynamic and dependent on factors such as subcellular location of miRNAs, abundancy of miRNAs and target mRNAs, and affinity of miRNA-mRNA interactions.
“The interaction of miRNAs with their target genes is dynamic and dependent on many factors, such as subcellular location of miRNAs, the abundancy of miRNAs and target mRNAs, and the affinity of miRNA-mRNA interactions.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPre-miRNAs are exported to the cytoplasm by an XPO5/RanGTP complex and then processed by Dicer.
“Once pre-miRNAs are generated, they are exported to the cytoplasm by an exportin 5 (XPO5)/RanGTP complex and then processed by the RNase III endonuclease Dicer (27, 30).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationmiRNAs are critical for normal animal development and are involved in a variety of biological processes.
“miRNAs are critical for normal animal development and are involved in a variety of biological processes (18).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Fu, 2013, MicroRNAs in human placental development and pregnancy complications, Int J Mol Sci. source
Not checked in the free run.
May combine two claims.
PremisecitationmiRNAs interact at genomic loci where enhancer-derived RNA are transcribed and increase mRNA levels of adjacent genes by promoting a transcriptionally active chromatin state while altering alternative splicing profiles.
“miRNAs have also been shown to interact at genomic loci, where enhancer-derived RNA (eRNA) are transcribed, and increase mRNA levels of adjacent genes by promoting a transcriptionally active chromatin state (67) while altering alternative splicing profiles (64).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [67] Xiao, 2017, MicroRNAs activate gene transcription epigenetically as an enhancer trigger, RNA Biol. source
Not checked in the free run.
- cites [64] Allo, 2014, Argonaute-1 binds transcriptional enhancers and controls constitutive and alternative splicing in human cells, Proc Natl Acad Sci USA. source
Not checked in the free run.
May combine two claims.
PremisecitationCooperation of multiple proximal MREs on target mRNA increases RNAi activity and increases retention times of miRISC complexes on those mRNA.
“Cooperation of multiple, proximal MREs on target mRNA has been shown to increase RNAi activity and increase retention times of miRISC complexes on those mRNA, most likely through the three AGO binding sites on the GW182 family proteins (94, 100).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [94] Denzler, 2016, Impact of MicroRNA levels, target-site complementarity, and cooperativity on competing endogenous RNA-regulated gene expression, Mol Cell source
Not checked in the free run.
- cites [100] Elkayam, 2017, Multivalent recruitment of human argonaute by GW182, Mol Cell. source
Not checked in the free run.
May combine two claims.
PremisecitationAlternative splicing and alternative polyadenylation affecting 3' UTRs, and cell type-specific RNA binding proteins that affect target mRNA secondary structures, change the available pool of MREs.
“Alternative splicing and alternative polyadenylation affecting 3′ UTRs, and cell type-specific RNA binding proteins that affect target mRNA secondary structures, change the available pool of MREs (63, 68, 69).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [63] Bottini, 2017, Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq, Nat Commun. source
Not checked in the free run.
- cites [68] Nam, 2014, Global analyses of the effect of different cellular contexts on microRNA targeting, Mol Cell. source
Not checked in the free run.
- cites [69] Blazie, 2017, Alternative polyadenylation directs tissue-specific miRNA targeting in Caenorhabditis elegans Somatic Tissues, Genetics source
Not checked in the free run.
May combine two claims.
Interpretationnone givenmiRNA-mediated gene regulation is dynamic and helps to buffer gene expression to a steady state.
“Studies have revealed that miRNA-mediated gene regulation is dynamic and helps to buffer gene expression to a steady state.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNuclear localized miRISC regulates both transcriptional rates and post-transcriptional levels of mRNA and associates with euchromatin at gene loci with active transcription.
“Nuclear localized miRISC was found to regulate both transcriptional rates and post-transcriptional levels of mRNA (59–61) and associate with euchromatin at gene loci with active transcription (62).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [59] Nishi, 2013, Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus, RNA source
Not checked in the free run.
- cites [60] Benhamed, 2012, Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells, Nat Cell Biol. source
Not checked in the free run.
- cites [61] Pitchiaya, 2017, Resolving subcellular miRNA trafficking and turnover at single-molecule resolution, Cell Rep. source
Not checked in the free run.
- cites [62] Cernilogar, 2011, Chromatin-associated RNA interference components contribute to transcriptional regulation in Drosophila, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationApproximately half of the expressed miRNAs are cell type enriched, one quarter are broadly expressed, and the remaining had low-level expression regardless of cell type.
“Moreover, approximately half of the expressed miRNAs are cell type enriched, one quarter are broadly expressed, and the remaining had low-level expression regardless of cell type.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] de Rie, 2017, An integrated expression atlas of miRNAs and their promoters in human and mouse, Nat Biotechnol. source
Not checked in the free run.
May combine two claims.
PremisecitationmiRISC has been found to copurify with polysomes, and the miRISC:mRNA complexes bound to these polysomes were associated with increased levels of translational inhibition and mRNA degradation.
“miRISC has also been found to copurify with polysomes, and the miRISC:mRNA complexes bound to these polysomes were associated with increased levels of translational inhibition and mRNA degradation (83).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83] Pillai, 2005, Inhibition of translational initiation by Let-7 MicroRNA in human cells, Science source
Not checked in the free run.
May combine two claims.
PremisecitationmiRNAs, AGO2, and target mRNAs are associated with rER-membrane-bound polysomes, and this occurs before miRNA-mediated translational repression.
“A recent study showed that miRNAs, AGO2, and target mRNAs are associated with rER-membrane-bound polysomes, and this occurs before miRNA-mediated translational repression (70).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] Barman, 2015, mRNA targeting to endoplasmic reticulum precedes ago protein interaction and microRNA (miRNA)-mediated translation repression in mammalian cells, J Biol Chem. source
Not checked in the free run.
May combine two claims.
PremisecitationCDKN1A is targeted by at least 28 miRNAs, many of which are upregulated together in cancers where CDKN1A has been implicated.
“For example, cyclin-dependent kinase inhibitor 1A (CDKN1A), a tumor suppressor that is downregulated in multiple cancers (106), is targeted by at least 28 miRNAs and many of which are upregulated together in cancers where CDKN1A has been implicated (107).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [106] Abbas, 2009, p21 in cancer: intricate networks and multiple activities, Nat Rev Cancer source
Not checked in the free run.
- cites [107] Wu, 2010, Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region, Oncogene source
Not checked in the free run.
May combine two claims.
PremisecitationThe degree of polysome occupancy of target mRNAs is dependent on the affinity between miRNA seed region and MRE, but not on miRNA abundance.
“Additionally, the degree of polysome occupancy of target mRNAs is dependent on the affinity between miRNA seed region and MRE, but not on miRNA abundance (84).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] Molotski, 2012, Differential association of microRNAs with polysomes reflects distinct strengths of interactions with their mRNA targets, RNA source
Not checked in the free run.
May combine two claims.
PremisecitationExtracellular miRNAs can be delivered to target cells and may act as autocrine, paracrine, and/or endocrine regulators to modulate cellular activities.
“The extracellular miRNAs can be delivered to target cells and they may act as autocrine, paracrine, and/or endocrine regulators to modulate cellular activities (116).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [116] Iftikhar, 2016, Evidence and potential in vivo functions for biofluid miRNAs: from expression profiling to functional testing: potential roles of extracellular miRNAs as indicators of physiological change and as agents of intercellular information exchange, Bioessays source
Not checked in the free run.
May combine two claims.
PremisecitationSecretion of exosomal miRNAs is mediated by a ceramide-dependent pathway and the secreted miRNAs exert growth regulatory effects in target cells.
“It has been shown that the secretion of exosomal miRNAs is mediated by a ceramide-dependent pathway and the secreted miRNAs exert growth regulatory effects in target cells (129).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Kosaka, 2010, Secretory mechanisms and intercellular transfer of microRNAs in living cells, J Biol Chem. source
Not checked in the free run.
May combine two claims.
PremisecitationBoth cell stress induced by heat shock and translation inhibition following treatment with hippuristanol or cycloheximide induced translocation of miRISC from the nucleus and cytoplasm to transient, cytoplasmic stress granules.
“Both cell stress induced by heat shock and translation inhibition following treatment with hippuristanol or cycloheximide induced translocation of miRISC from the nucleus and cytoplasm to transient, cytoplasmic SG (72, 111).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [72] Detzer, 2011, Cell stress is related to re-localization of Argonaute 2 and to decreased RNA interference in human cells, Nucleic Acids Res. source
Not checked in the free run.
- cites [111] Leung, 2006, Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules, Proc Natl Acad Sci USA. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSeveral studies found that the majority of extracellular miRNAs are not associated with exosomes/microvesicles but are instead bound to AGO2.
“While several studies found that the majority of extracellular miRNAs are not associated with exosomes/microvesicles but are instead bound to AGO2 (118, 125), another study reported that extracellular miRNAs are present predominantly in exosomes in human serum and saliva (120).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [118] Arroyo, 2011, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [125] Turchinovich, 2011, Characterization of extracellular circulating microRNA, Nucleic Acids Res. source
Not checked in the free run.
May combine two claims.
PremisecitationExtracellular miRNAs bind to Toll-like receptors, activate downstream signaling events, and lead to biological responses such as tumor growth, metastasis, and neurodegeneration.
“Extracellular miRNAs have also been reported to bind to Toll-like receptors (137), activate downstream signaling events, and eventually lead to biological responses, such as tumor growth and metastasis (138), and neurodegeneration (139).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [137] Fabbri, 2018, MicroRNAs and miRceptors: a new mechanism of action for intercellular communication, Philos Trans R Soc Lond B Biol Sci. source
Not checked in the free run.
- cites [138] Fabbri, 2012, MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response, Proc Natl Acad Sci USA. source
Not checked in the free run.
- cites [139] Lehmann, 2012, An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration, Nat Neurosci. source
Not checked in the free run.
May combine two claims.
PremisecitationExosome-mediated transfer of miR-105 from metastatic breast cancer cells to endothelial cells directly targeted ZO-1, leading to destruction of endothelial barrier function and promoted metastasis.
“For example, exosome mediated transfer of miR-105 from metastatic breast cancer cells to endothelial cells directly targeted a tight junction protein, zonula occludens 1 (ZO-1), and this led to the destruction of the barrier function of endothelium and promoted metastasis (134).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [134] Zhou, 2014, Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis, Cancer Cell source
Not checked in the free run.
May combine two claims.
PremisecitationThe presence of miRNAs in vesicles or with accompanying proteins is generally thought to protect extracellular miRNAs and increase their stability in the extracellular milieu.
“The presence of miRNAs in vesicles or with accompanying proteins is generally thought to protect extracellular miRNAs and increase their stability in the extracellular milieu (120).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [120] Gallo, 2012, The majority of microRNAs detectable in serum and saliva is concentrated in exosomes, PLoS ONE source
Not checked in the free run.
May combine two claims.
PremisecitationIn PC12 cells, miRNA entry by endocytosis/micropinocytosis is dependent on clathrin, but not on caveolae or lipid rafts.
“This process has been reported to be dependent on clathrin, but not on caveolae or lipid rafts in PC12 cells (142).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [142] Tian, 2014, Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery, J Biol Chem. source
Not checked in the free run.
May combine two claims.
PremisecitationIn neuroendocrine cells, miRNAs in large dense-core vesicles are released by exocytosis through vesicle fusion, and this process is mediated by the SNARE complex and accelerated by Ca2+ stimulus.
“In neuroendocrine cells, miRNAs in large dense-core vesicles (LDCVs) are released by exocytosis through vesicle fusion, and this process is mediated by the SNARE complex and accelerated by Ca2+ stimulus (131).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [131] Gumurdu, 2017, MicroRNA exocytosis by large dense-core vesicle fusion, Sci Rep. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnother study reported that extracellular miRNAs are present predominantly in exosomes in human serum and saliva.
“another study reported that extracellular miRNAs are present predominantly in exosomes in human serum and saliva (120).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [120] Gallo, 2012, The majority of microRNAs detectable in serum and saliva is concentrated in exosomes, PLoS ONE source
Not checked in the free run.
May combine two claims.
PremisecitationTwo populations of extracellular miRNAs exist in biological fluids: one in vesicles such as exosomes, microvesicles, and apoptotic bodies, and the other associated with proteins, especially AGO2.
“Two populations of extracellular miRNAs exist in biological fluids. One can be found in vesicles such as exosomes, microvesicles, and apoptotic bodies (116, 120) while the other is associated with proteins, especially AGO2 (120, 125).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [116] Iftikhar, 2016, Evidence and potential in vivo functions for biofluid miRNAs: from expression profiling to functional testing: potential roles of extracellular miRNAs as indicators of physiological change and as agents of intercellular information exchange, Bioessays source
Not checked in the free run.
- cites [120] Gallo, 2012, The majority of microRNAs detectable in serum and saliva is concentrated in exosomes, PLoS ONE source
Not checked in the free run.
- cites [125] Turchinovich, 2011, Characterization of extracellular circulating microRNA, Nucleic Acids Res. source
Not checked in the free run.
May combine two claims.
PremisecitationExosomes from umbilical cord blood are enriched in miR-21-3p, which promotes proliferation and migration of fibroblasts and induces angiogenic activities of endothelial cells, leading to accelerated wound healing.
“Moreover, exosomes from umbilical cord blood were found to be enriched in miR-21-3p, which promoted the proliferation and migration of fibroblasts, and induced the angiogenic activities of endothelial cells, leading to accelerated wound healing (135).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [135] Hu, 2018, Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function, Theranostics source
Not checked in the free run.
May combine two claims.
PremisecitationUpon serum starvation of multiple human cell lines, there was an immediate exportation of stable, vesicular or vesicle-free miRNA and a concomitant decrease of intracellular miRNA levels.
“In a study by Wang et al. (110), upon serum starvation of multiple human cell lines, there was an immediate exportation of stable, vesicular or vesicle-free miRNA and a concomitant decrease of intracellular miRNA levels (110).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [110] Wang, 2010, Export of microRNAs and microRNA-protective protein by mammalian cells, Nucleic Acids Res. source
Not checked in the free run.
Classified as probably not a substantial claim.
Interpretationnone givenMechanisms by which miRNAs are secreted and taken up by cells are not well understood.
“Mechanisms by which miRNAs are secreted and taken up by cells are not well understood and require further investigation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Interpretationnone givenmiRNAs are powerful gene regulators.
“It is now clear that miRNAs are powerful gene regulators, and that they not only help control mRNA stability and translation but are also involved in transcription.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Interpretationnone givenmiRNA activity in a test tube may not be recapitulated within the cellular environment.
“The assaying of miRNA activity within a test tube may not be recapitulated within the cellular environment and thus should be viewed with caution.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningChemical tags on miRNA could impact miRNA:MRE interaction or AGO:miRNA interactions, specifically with 5′ and 3′ miRNA nucleotide modifications.
“Also, the addition of chemical tags to miRNA could also impact miRNA:MRE interaction or AGO:miRNA interactions, specifically with 5′ and 3′ miRNA nucleotide modifications.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenmiRNAs are secreted and transferred to recipient cells.
“miRNAs regulate the activity of host cells, and they are also secreted and transferred to recipient cells.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenOur understanding of when and how miRNAs can exert regulatory effects on transcription is limited.
“However, our understanding of when and how miRNAs can exert regulatory effects on transcription is limited.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenMany factors contribute to the activity of miRNAs, including subcellular location, miRNA/mRNA abundance, miRNA:MRE affinity, cell type/state, and availability of various miRISC components.
“Many factors contribute to the activity of miRNAs, including subcellular location, miRNA/mRNA abundance, miRNA:MRE affinity, cell type/state, and the availability of various miRISC components.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenCytosolic miRISC components shuttle between different compartments.
“Cytosolic miRISC components shuttle between different compartments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Study design and conductnone givenMost studies conducted so far were done in vitro using co-culture of different cell types.
“However, most studies conducted so far were done in vitro using co-culture of different cell types.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenmiRNAs in the nucleus play a role in regulating transcription and alternative splicing.
“miRNAs in the nucleus play a role in regulating transcription and alternative splicing.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The first and last miRNA nucleotides clamp the miRNA within AGO proteins.
“The first and last miRNA nucleotides clamp the miRNA within AGO proteins”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Translation of any synthetic mRNA released into the cytoplasm may be blocked by micro ribonucleic acid.
“Additionally, translation of any synthetic mRNA released into the cytoplasm may be blocked by micro ribonucleic acid (microRNA) [44].”
From Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy (2022) · cites this paper as [44]
The paper’s “Mechanisms of miRNA-mediated gene regulation” section says miRNAs repress translation by binding specific sequences in target mRNAs. Its “Subcellular compartmentalization of miRNAs” section also describes translational inhibition in the cytoplasm. It does not establish that any synthetic mRNA released into the cytoplasm can be blocked; targeting depends on a suitable binding sequence. (LLM, conf=0.86)
Experimental — accuracy not yet measuredOther non-coding regulatory mechanisms (miRNAs, lncRNAs, transposable elements) could alter gene expression in AD and are not assessed in this study.
“Although this study is focused on identifying CREs, there are other non-coding regulatory mechanisms that could alter gene expression in AD including microRNAs (miRNAs),90 long non-coding RNAs (lncRNAs),91 transposable elements,92 etc., that are not assessed.”
From Single nucleus multiomics identifies ZEB1 and MAFB as candidate regulators of Alzheimer’s disease-specific cis-regulatory elements (2023) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
miRNA identifier differs from the cited study
MinorThe text attributes suppression of CYP2E1 transcription to miR-522, but the title of the cited study identifies the miRNA as miR-552.
“A more recent study by Miao et al. (66) found nuclear miR-522 interacting with a DNA cruciform structure (a stem-loop on sense and antisense DNA strands) within the promoter of CYP2E1 and suppressing its transcription (66).”
“66. Miao L Yao H Li C Pu M Yao X Yang H. A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1.”
Flow condition differs from the cited study
MinorThe text describes the cited secretion finding as induced by atheroprotective laminar shear stress, whereas the cited study's title identifies disturbed flow as the inducing condition.
“Recently, it was demonstrated that atheroprotective laminar shear stress induced the release of vesicle-free miR-126-3p and other miRNAs, as well as AGO2, from endothelial cells by activating vesicle-associated membrane protein 3 (VAMP3) and synaptosomal-associated protein 23 (SNAP23) (130).”
“130. Zhu JJ Liu YF Zhang YP Zhao CR Yao WJ Li YS. VAMP3 and SNAP23 mediate the disturbed flow-induced endothelial microRNA secretion and smooth muscle hyperplasia.”
Cites
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948 · see citing works
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969 · see citing works
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1× · see citing works
“for any given gene is the rate of translation, followed by mRNA levels (93).”
BackgroundRegulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462 · see citing works
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560 · see citing works
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292 · see citing works
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · see citing works
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294 · see citing works
Processing of primary microRNAs by the Microprocessor complex
Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F., & Hannon, G. J. (2004) · Nature · doi:10.1038/nature03049 · Cited by 2,784 · see citing works
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y. C., Huang, K., Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,754 · see citing works
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., & Remaley, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2210 · Cited by 2,741 · see citing works
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · see citing works
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645 · see citing works
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA
Pasquinelli, A. E., Reinhart, B. J., Slack, F. J., Martindale, M. Q., Kuroda, M. I., Maller, B., Hayward, D. C., Ball, E. E., Degnan, B. M., Müller, P., et al. (2000) · Nature · doi:10.1038/35040556 · Cited by 2,568 · see citing works
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Huntzinger, E., & Izaurralde, E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2936 · Cited by 2,339 · see citing works
The Drosha-DGCR8 complex in primary microRNA processingPreprint
Han, J., Lee, Y., Yeom, K.-H., Kim, Y. K., Jin, H., & Kim, V. N. (2004) · Genes & Development · doi:10.1101/gad.1262504 · Cited by 2,208 · see citing works
MicroRNAs in cancer: biomarkers, functions and therapy
Hayes, J., Peruzzi, P. P., & Lawler, S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.005 · Cited by 2,049 · see citing works
Characterization of extracellular circulating microRNA
Turchinovich, A., Weiz, L., Langheinz, A., & Burwinkel, B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr254 · Cited by 1,941 · see citing works
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., & Ochiya, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107821 · Cited by 1,934 · see citing works
Towards a molecular understanding of microRNA-mediated gene silencing
Jonas, S., & Izaurralde, E. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3965 · Cited by 1,872 · see citing works
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions
Chou, C., Shrestha, S., Yang, C.-D., Chang, N.-W., Lin, Y., Liao, K., Huang, W.-C., Sun, T.-H., Tu, S.-J., Lee, W.-H., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1067 · Cited by 1,813 · see citing works
Principles and Properties of Stress Granules
Protter, D. S. W., & Parker, R. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.05.004 · Cited by 1,738 · see citing works
Roles for MicroRNAs in Conferring Robustness to Biological Processes
Ebert, M. S., & Sharp, P. A. (2012) · Cell · doi:10.1016/j.cell.2012.04.005 · Cited by 1,564 · see citing works
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209414109 · Cited by 1,558 · see citing works
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476 · see citing works
Intronic microRNA precursors that bypass Drosha processing
Ruby, J. G., Jan, C. H., & Bartel, D. P. (2007) · Nature · doi:10.1038/nature05983 · Cited by 1,445 · see citing works
Inhibition of Translational Initiation by Let-7 MicroRNA in Human Cells
Pillai, R. S., Bhattacharyya, S. N., Artus-Revel, C. G., Zoller, T., Cougot, N., Basyuk, E. I., Bertrand, É., & Filipowicz, W. (2005) · Science · doi:10.1126/science.1115079 · Cited by 1,431 · see citing works
N6-methyladenosine marks primary microRNAs for processing
Alarcón, C. R., Lee, H., Goodarzi, H., Halberg, N., & Tavazoie, S. F. (2015) · Nature · doi:10.1038/nature14281 · Cited by 1,394 · see citing works
MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation
Ørom, U. A., Nielsen, F. C., & Lund, A. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.001 · Cited by 1,384 · see citing works
P bodies and the control of mRNA translation and degradation
Parker, R., & Sheth, U. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.011 · Cited by 1,335 · see citing works
MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies
Liu, J., Valencia-Sanchez, M. A., Hannon, G. J., & Parker, R. (2005) · Nature Cell Biology · doi:10.1038/ncb1274 · Cited by 1,234 · see citing works
The majority of microRNAs detectable in serum and saliva is concentrated in exosomes
Gallo, A., Tandon, M., Alevizos, I., & Illei, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030679 · Cited by 1,060 · see citing works
Single Processing Center Models for Human Dicer and Bacterial RNase III
Zhang, H., Kolb, F. A., Jaśkiewicz, Ł., Westhof, É., & Filipowicz, W. (2004) · Cell · doi:10.1016/j.cell.2004.06.017 · Cited by 1,043 · see citing works
Behm‐Ansmant, I., Rehwinkel, J., Doerks, T., Stark, A., Bork, P., & Izaurralde, E. (2006) · Genes & Development · doi:10.1101/gad.1424106 · Cited by 1,030 · see citing works
A dicer-independent miRNA biogenesis pathway that requires Ago catalysis
Cheloufi, S., Dos Santos, C. O., Chong, M. M. W., & Hannon, G. J. (2010) · Nature · doi:10.1038/nature09092 · Cited by 1,026 · see citing works
Export of microRNAs and microRNA-protective protein by mammalian cells
Wang, K., Zhang, S., Weber, J., Baxter, D., & Galas, D. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq601 · Cited by 1,002 · see citing works
Gibbings, D., Ciaudo, C., Erhardt, M., & Voinnet, O. (2009) · Nature Cell Biology · doi:10.1038/ncb1929 · Cited by 990 · see citing works
Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943 · see citing works
Babiarz, J., Ruby, J. G., Wang, Y., Bartel, D. P., & Blelloch, R. H. (2008) · Genes & Development · doi:10.1101/gad.1705308 · Cited by 905 · see citing works
Processing of intronic microRNAs
Kim, Y. K., & Kim, V. N. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601512 · Cited by 869 · see citing works
Circular RNAs: analysis, expression and potential functions
Barrett, S. P., & Salzman, J. (2016) · Development · doi:10.1242/dev.128074 · Cited by 859 · see citing works
MicroRNA as Biomarkers and Diagnostics
Wang, J., Chen, J., & Sen, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25056 · Cited by 793 · see citing works
Secreted microRNAs: a new form of intercellular communication
Chen, X., Liang, H., Zhang, J., Zen, K., & Zhang, C. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.12.001 · Cited by 761 · see citing works
Tian, T., Zhu, Y.-L., Zhou, Y.-Y., Liang, G.-F., Wang, Y.-Y., Hu, F.-H., & Xiao, Z.-D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.588046 · Cited by 726 · see citing works
P-body formation is a consequence, not the cause, of RNA-mediated gene silencing
Eulalio, A., Behm-Ansmant, I., Schweizer, D., & Izaurralde, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00128-07 · Cited by 710 · see citing works
An unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration
Lehmann, S. M., Krüger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3113 · Cited by 697 · see citing works
Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., Liu, Y., Huang, J.-D., & Song, E. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-117 · Cited by 693 · see citing works
AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2
Vasudevan, S., & Steitz, J. A. (2007) · Cell · doi:10.1016/j.cell.2007.01.038 · Cited by 656 · see citing works
Molecular Evolution of a MicroRNA Cluster
Andrea Tanzer, A., & Stadler, P. F. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.03.065 · Cited by 636 · see citing works
Immune-related MicroRNAs are Abundant in Breast Milk Exosomes
Zhou, Q. G., Li, M., Wang, X., Li, Q., Wang, T., Zhu, Q., Zhou, X., Wang, X., Gao, X., & Li, X. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.8.118 · Cited by 607 · see citing works
Target RNA–Directed Trimming and Tailing of Small Silencing RNAs
Ameres, S. L., Horwich, M. D., Hung, J.-H., Xu, J., Ghildiyal, M., Weng, Z., & Zamore, P. D. (2010) · Science · doi:10.1126/science.1187058 · Cited by 597 · see citing works
Forman, J. J., Legesse-Miller, A., & Coller, H. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803230105 · Cited by 581 · see citing works
Hu, Y., Rao, S.-S., Wang, Z.-X., Cao, J., Tan, Y.-J., Luo, J., Li, H.-M., Zhang, W.-S., Chen, C.-Y., & Xie, H. (2018) · Theranostics · doi:10.7150/thno.21234 · Cited by 574 · see citing works
The role of microRNAs in human diseases
Tüfekci, K. U., Öner, M. G., Meuwissen, R. L. J., & Genç, Ş. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-748-8_3 · Cited by 566 · see citing works
An integrated expression atlas of miRNAs and their promoters in human and mouse
The FANTOM Consortium, de Rie, D., Abugessaisa, I., Alam, T., Arner, E., Arner, P., Ashoor, H., Åström, G., Babina, M., Bertin, N., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3947 · Cited by 561 · see citing works
Mutations that lead to reiterations in the cell lineages of C. elegans.
Chalfie, M., Horvitz, H., & Sulston, J. (1981) · Cell · doi:10.1016/0092-8674(81)90501-8 · Cited by 541 · see citing works
Extracellular miRNAs: the mystery of their origin and function
Turchinovich, A. A., Weiz, L., & Burwinkel, B. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.08.003 · Cited by 520 · see citing works
Posttranscriptional Upregulation by MicroRNAs
Vasudevan, S. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.121 · Cited by 512 · see citing works
MicroRNA Directly Enhances Mitochondrial Translation during Muscle Differentiation
Zhang, X., Zuo, X., Yang, B., Li, Z., Xue, Y., Zhou, Y., Huang, J. S., Zhao, X., Zhou, J., Yan, Y., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.047 · Cited by 488 · see citing works
Pairing beyond the Seed Supports MicroRNA Targeting Specificity
Broughton, J. P., Lovci, M. T., Huang, J. L., Yeo, G. W., & Pasquinelli, A. E. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.004 · Cited by 487 · see citing works
A High-Resolution Structure of the Pre-microRNA Nuclear Export Machinery
岡田, 千., Yamashita, E., Lee, S. J., Shibata, S., Katahira, J., Nakagawa, A., Yoneda, Y., & Tomitake Tsukihara, A. (2009) · Science · doi:10.1126/science.1178705 · Cited by 486 · see citing works
Yang, J.-S., Maurin, T., Robine, N., Rasmussen, K. D., Jeffrey, K. L., Chandwani, R., Papapetrou, E. P., Sadelain, M., O’Carroll, D., & Lai, E. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006432107 · Cited by 481 · see citing works
Kawamata, T., & Tomari, Y. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.03.009 · Cited by 481 · see citing works
da Silveira, J. C., Veeramachaneni, D. N. R., Winger, Q. A., Carnevale, E. M., & Bouma, G. J. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.093252 · Cited by 441 · see citing works
Horvitz, H., & Sulston, J. (1980) · Genetics · doi:10.1093/genetics/96.2.435 · Cited by 429 · see citing works
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells
Tabet, F., Vickers, K. C., Cuesta Torres, L. F., Wiese, C. B., Shoucri, B. M., Lambert, G., Catherinet, C., Prado-Lourenco, L., Levin, M. G., Thacker, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4292 · Cited by 428 · see citing works
Leung, A., Calabrese, J. M., & Sharp, P. (2006) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0608845103 · Cited by 428 · see citing works
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma
Sohn, W., Kim, J., Kang, S. H., Yang, S. R., Cho, J., Cho, H. C., Shim, S. G., & Paik, Y. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.68 · Cited by 427 · see citing works
Interplay between miRNAs and human diseases
Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., Singha, R. S., Malakar, A. K., & Chakraborty, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25854 · Cited by 420 · cited 1× · see citing works
“Aberrant expression of miRNAs is associated with many human diseases (19, 20).”
BackgroundCompeting endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation
Kartha, R. V., & Subramanian, S. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00008 · Cited by 402 · see citing works
MicroRNA control of protein expression noise
Schmiedel, J. M., Klemm, S. L., Zheng, Y., Sahay, A., Blüthgen, N., Marks, D. S., & van Oudenaarden, A. (2015) · Science · doi:10.1126/science.aaa1738 · Cited by 395 · see citing works
Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region
Wu, S., Huang, S., Ding, J., Zhao, Y., Liang, L., Liu, T., Zhan, R., & He, X. (2010) · Oncogene · doi:10.1038/onc.2010.34 · Cited by 394 · see citing works
Argonaute Divides Its RNA Guide into Domains with Distinct Functions and RNA-Binding Properties
Wee, L. M., Flores-Jasso, C. F., Salomon, W. E., & Zamore, P. D. (2012) · Cell · doi:10.1016/j.cell.2012.10.036 · Cited by 392 · see citing works
ATP-dependent human RISC assembly pathways
Yoda, M., Kawamata, T., Paroo, Z., Ye, X., Iwasaki, S., Liu, Q., & Tomari, Y. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1733 · Cited by 380 · see citing works
MicroRNAs activate gene transcription epigenetically as an enhancer trigger
Xiao, M., Li, J., Li, W., Wang, Y., Wu, F., Xi, Y., Zhang, L., Ding, C., Luo, H., Li, Y., et al. (2016) · RNA Biology · doi:10.1080/15476286.2015.1112487 · Cited by 378 · see citing works
RNAi Factors Are Present and Active in Human Cell Nuclei
Gagnon, K. T., Li, L., Chu, Y., Janowski, B. A., & Corey, D. R. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.013 · Cited by 367 · see citing works
MicroRNA history: Discovery, recent applications, and next frontiers
Almeida, M. I., Reis, R. M., & Calin, G. A. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.03.009 · Cited by 349 · see citing works
Denzler, R., McGeary, S. E., Title, A. C., Agarwal, V., Bartel, D. P., & Stoffel, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.027 · Cited by 340 · see citing works
Global Analyses of the Effect of Different Cellular Contexts on MicroRNA Targeting
Nam, J., Rissland, O. S., Koppstein, D., Abreu‐Goodger, C., Jan, C. H., Agarwal, V., Yıldırım, M. A., Rodríguez, A., & Bartel, D. P. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.02.013 · Cited by 337 · see citing works
The circular RNA circBIRC6 participates in the molecular circuitry controlling human pluripotency
Yu, C.-Y., Li, T.-C., Wu, Y.-Y., Yeh, C.-H., Chiang, W., Chuang, C.-Y., & Kuo, H.-C. (2017) · Nature Communications · doi:10.1038/s41467-017-01216-w · Cited by 336 · see citing works
A genetic pathway for the specification of the vulval cell lineages of Caenorhabditis elegans
Ferguson, E. L., Sternberg, P. W., & Horvitz, H. R. (1987) · Nature · doi:10.1038/326259a0 · Cited by 334 · see citing works
Pre-microRNA and Mature microRNA in Human Mitochondria
Barrey, É., Saint‐Auret, G., Bonnamy, B., Damas, D., Boyer, O., & Gidrol, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020220 · Cited by 317 · see citing works
Mechanisms of control of microRNA biogenesis
Davis‐Dusenbery, B. N., & Hata, A. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq096 · Cited by 289 · see citing works
MicroRNAs in Human Placental Development and Pregnancy Complications
Fu, G., Brkić, J., Hayder, H., & Peng, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035519 · Cited by 286 · see citing works
Self-citationFrom guide to target: molecular insights into eukaryotic RNA-interference machinery
Ipsaro, J. J., & Joshua-Tor, L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2931 · Cited by 281 · see citing works
Zhang, J., Fu, W., He, M., et al. (2011) · RNA Biology · doi:10.4161/rna.8.5.16043 · Cited by 270 · see citing works
Intracellular and extracellular microRNA: An update on localization and biological role
Makarova, J. A., Shkurnikov, M. Y., Wicklein, D., Lange, T., Samatov, T. R., Turchinovich, A. A., & Tonevitsky, A. (2016) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2016.06.001 · Cited by 260 · see citing works
Evidence for the biogenesis of more than 1,000 novel human microRNAs
Friedländer, M. R., Lizano, E., Houben, A. J. S., Bezdan, D., Báñez-Coronel, M., Kudla, G., Mateu-Huertas, E., Kagerbauer, B., González, J., Chen, K. C., et al. (2014) · Genome biology · doi:10.1186/gb-2014-15-4-r57 · Cited by 257 · see citing works
Mammalian 5′-Capped MicroRNA Precursors that Generate a Single MicroRNA
Xie, M., Li, M., Vilborg, A., Lee, N., Shu, M.-D., Yartseva, V., Šestan, N., & STEITZ, J. A. (2013) · Cell · doi:10.1016/j.cell.2013.11.027 · Cited by 256 · see citing works
Benhamed, M., Herbig, U., Ye, T., Dejean, A., & Bischof, O. (2012) · Nature Cell Biology · doi:10.1038/ncb2443 · Cited by 252 · see citing works
MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation
Aucher, A., Rudnicka, D., & Davis, D. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301728 · Cited by 247 · see citing works
Wei, F., Ma, C., Zhou, T., Dong, X., Luo, Q., Geng, L., Ding, L., Zhang, Y., Zhang, L., Li, N., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0694-8 · Cited by 245 · see citing works
MicroRNAs: biomarkers, diagnostics, and therapeutics
Huang, W. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7046-9_4 · Cited by 237 · see citing works
Regulation of miRNA strand selection: follow the leader?
Meijer, H. A., Smith, E. M., & Bushell, M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140142 · Cited by 233 · see citing works
Cernilogar, F. M., Onorati, M. C., Kothe, G. O., Burroughs, A. M., Parsi, K. M., Breiling, A., Sardo, F. L., Saxena, A., Miyoshi, K., Siomi, H., et al. (2011) · Nature · doi:10.1038/nature10492 · Cited by 228 · see citing works
A short history of a short RNA
Lee, R., Feinbaum, R. L., & Ambros, V. (2004) · Cell · doi:10.1016/s0092-8674(04)00035-2 · Cited by 224 · see citing works
Hannafon, B. N., Carpenter, K. J., Berry, W. L., Janknecht, R., Dooley, W. C., & Ding, W.-Q. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0400-7 · Cited by 218 · see citing works
Human Argonaute 2 Has diverse reaction pathways on Target RNAs
Jo, M. H., Shin, S., Jung, S.-R., Kim, E., Song, J.-J., & Hohng, S. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.027 · Cited by 207 · see citing works
Sakha, S., Muramatsu, T., Ueda, K., & Inazawa, J. (2016) · Scientific Reports · doi:10.1038/srep38750 · Cited by 201 · see citing works
Ambros, V., & Horvitz, H. R. (1987) · Genes & Development · doi:10.1101/gad.1.4.398 · Cited by 197 · see citing works
Understanding microRNA-mediated gene regulatory networks through mathematical modelling
Lai, X., Wolkenhauer, O., & Vera, J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw550 · Cited by 192 · see citing works
Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus
Nishi, K., Nishi, A., Nagasawa, T., & Ui-Tei, K. (2013) · RNA · doi:10.1261/rna.034769.112 · Cited by 188 · see citing works
A direct interaction between DCP1 and XRN1 couples mRNA decapping to 5′ exonucleolytic degradation
Braun, J. E., Truffault, V., Boland, A., Huntzinger, E., Chang, C.-T., Haas, G., Weichenrieder, O., Coles, M. P., & Izaurralde, E. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2413 · Cited by 180 · see citing works
Activity-dependent spatially localized miRNA maturation in neuronal dendrites
Sambandan, S., Akbalık, G., Kochen, L., Rinne, J. S., Kahlstatt, J., Glock, C., Tushev, G., Alvarez‐Castelao, B., Heckel, A., & Schuman, E. M. (2017) · Science · doi:10.1126/science.aaf8995 · Cited by 179 · see citing works
Truesdell, S. S., Mortensen, R. D., Seo, M., Schroeder, J. C., Lee, J. H., LeTonqueze, O., & Vasudevan, S. (2012) · Scientific Reports · doi:10.1038/srep00842 · Cited by 173 · see citing works
MiRNAs confer phenotypic robustness to gene networks by suppressing biological noise
Siciliano, V., Garzilli, I., Fracassi, C., Criscuolo, S., Ventre, S., & di Bernardo, D. (2013) · Nature Communications · doi:10.1038/ncomms3364 · Cited by 166 · see citing works
Evolutionary Convergence of Pathway-Specific Enzyme Expression Stoichiometry
Lalanne, J., Taggart, J., Guo, M. S., Herzel, L., Schieler, A., & Li, G. (2018) · Cell · doi:10.1016/j.cell.2018.03.007 · Cited by 166 · see citing works
Identifying microRNA targets in different gene regions
Xu, W., San Lucas, A., Wang, Z., & Liu, Y. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s7-s4 · Cited by 159 · see citing works
MicroRNAs: crucial regulators of placental development
Hayder, H., O’Brien, J. A., Nadeem, U., & Peng, C. (2018) · Reproduction · doi:10.1530/rep-17-0603 · Cited by 157 · see citing works
Self-citationMicroRNA miR-324-3p induces promoter-mediated expression of RelA gene
Dharap, A., Pokrzywa, C., Murali, S., Pandi, G., & Vemuganti, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079467 · Cited by 154 · see citing works
Identification of homologous microRNAs in 56 animal genomes
Li, S., Chan, W., Hu, L., Lai, C.-H., Hsu, C., & Lin, W. (2010) · Genomics · doi:10.1016/j.ygeno.2010.03.009 · Cited by 145 · see citing works
Circulating microRNAs as markers of liver inflammation, fibrosis and cancer
Roderburg, C., & Luedde, T. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.017 · Cited by 121 · see citing works
The sufficient minimal set of miRNA seed types
Ellwanger, D. C., Büttner, F. A., Mewes, H.-W., & Stümpflen, V. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr149 · Cited by 112 · see citing works
Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5′ UTR of RUNX3
Zhang, J., Zhou, W., Liu, Y., Liu, T., Li, C., & Wang, L. (2018) · Oncology Letters · doi:10.3892/ol.2018.8217 · Cited by 112 · see citing works
Christie, M., Boland, A., Huntzinger, E., Weichenrieder, O., & Izaurralde, E. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.011 · Cited by 106 · see citing works
A Specialized Mechanism of Translation Mediated by FXR1a-Associated MicroRNP in Cellular Quiescence
Bukhari, S. I. A., Truesdell, S. S., Lee, S., Kollu, S., Classon, A., Boukhali, M., Jain, E., Mortensen, R. D., Yanagiya, A., Sadreyev, R. I., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.013 · Cited by 106 · see citing works
Multivalent Recruitment of Human Argonaute by GW182
Elkayam, E., Faehnle, C. R., Morales, M., Sun, J., Li, H., & Joshua‐Tor, L. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.007 · Cited by 101 · see citing works
Alló, M., Agirre, E., Bessonov, S., Bertucci, P., Acuña, L. I. G., Buggiano, V., Bellora, N., Singh, B., Petrillo, E., Blaustein, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416858111 · Cited by 98 · see citing works
Resolving subcellular miRNA trafficking and turnover at single-molecule resolution
Pitchiaya, S., Heinicke, L. A., Park, J. I., Cameron, E. L., & Walter, N. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.075 · Cited by 98 · see citing works
A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1
Miao, L., Yao, H., Li, C., Pu, M., Yao, X., Yang, H., Qi, X., Ren, J., & Wang, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.016 · Cited by 98 · see citing works
Microtubule disruption targets HIF-1α mRNA to cytoplasmic P-bodies for translational repression
Carbonaro, M., O’Brate, A., & Giannakakou, P. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201004145 · Cited by 95 · see citing works
Dynamic and Modularized MicroRNA Regulation and Its Implication in Human Cancers
Shu, J., Silva, B. V. R. E., Gao, T. X., Xu, Z. Q., & Cui, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-13470-5 · Cited by 89 · see citing works
Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq
Bottini, S., Hamouda-Tekaya, N., Mategot, R., Zaragosi, L.-E., Audebert, S., Pisano, S., Grandjean, V., Mauduit, C., Benahmed, M., Barbry, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01126-x · Cited by 89 · see citing works
Iftikhar, H., & Carney, G. E. (2016) · BioEssays · doi:10.1002/bies.201500130 · Cited by 87 · see citing works
Barman, B., & Bhattacharyya, S. N. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.c115.661868 · Cited by 86 · see citing works
Mirsynergy: detecting synergistic miRNA regulatory modules by overlapping neighbourhood expansion
Li, Y., Liang, C., Wong, K.-C., Luo, J., & Zhang, Z. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu373 · Cited by 83 · see citing works
Detzer, A., Engel, C., Wünsche, W., & Sczakiel, G. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1216 · Cited by 74 · see citing works
Blazie, S. M., Geissel, H. C., Wilky, H., Joshi, R., Newbern, J. M., & Mangone, M. (2017) · Genetics · doi:10.1534/genetics.116.196774 · Cited by 74 · see citing works
MicroRNAs and miRceptors: a new mechanism of action for intercellular communication
Fabbri, M. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0486 · Cited by 65 · see citing works
Xu, J., Chen, Q., Zen, K., Zhang, C., & Zhang, Q. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12057 · Cited by 61 · see citing works
Drosha Promotes Splicing of a Pre-microRNA-like Alternative Exon
Havens, M. A., Reich, A. A., & Hastings, M. L. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004312 · Cited by 61 · see citing works
Synergic functions of miRNAs determine neuronal fate of adult neural stem cells
Pons-Espinal, M., de Luca, E., Marzi, M. J., Beckervordersandforth, R., Armirotti, A., Nicassio, F., Fabel, K., Kempermann, G., & De Pietri Tonelli, D. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.02.012 · Cited by 59 · see citing works
Zhu, J.-J., Liu, Y.-F., Zhang, Y.-P., Zhao, C.-R., Yao, W.-J., Li, Y.-S., Wang, K.-C., Huang, T.-S., Pang, W., Wang, X.-F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700561114 · Cited by 56 · see citing works
Kucherenko, M. M., & Shcherbata, H. R. (2018) · Journal of Cell Science · doi:10.1242/jcs.202002 · Cited by 55 · see citing works
Pereira‐da‐Silva, T., Cruz, M. C., Carrusca, C., Ferreira, F., Napoleão, P., & Carmo, M. M. (2018) · Europe PMC (PubMed Central) · Cited by 53 · see citing works
Bose, M., Barman, B., Goswami, A., & Bhattacharyya, S. N. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00464-16 · Cited by 48 · see citing works
Control of the localization and function of a miRNA silencing component TNRC6A by Argonaute protein
Nishi, K., Takahashi, T., Suzawa, M., Miyakawa, T., Nagasawa, T., Ming, Y., Tanokura, M., & Ui-Tei, K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1026 · Cited by 43 · see citing works
Target-dependent biogenesis of cognate microRNAs in human cells
Bose, M., & Bhattacharyya, S. N. (2016) · Nature Communications · doi:10.1038/ncomms12200 · Cited by 38 · see citing works
Yao, W., Guo, G., Zhang, Q., Fan, L., Wu, N., & Bo, Y. (2014) · Virology · doi:10.1016/j.virol.2014.04.007 · Cited by 36 · see citing works
Mammalian microtubule P-body dynamics are mediated by nesprin-1
Rajgor, D., Mellad, J. A., Soong, D., Rattner, J. B., Fritzler, M. J., & Shanahan, C. M. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201306076 · Cited by 26 · see citing works
Molotski, N., & Soen, Y. (2012) · RNA · doi:10.1261/rna.033142.112 · Cited by 26 · see citing works
MicroRNA exocytosis by large dense-core vesicle fusion
Gümürdü, A., Yildiz, R., Eren, E., Karakülah, G., Ünver, T., Genç, Ş., & Park, Y. (2017) · Scientific Reports · doi:10.1038/srep45661 · Cited by 21 · see citing works
Dissecting miRNA gene repression on single cell level with an advanced fluorescent reporter system
Lemus-Diaz, N., Böker, K. O., Rodriguez-Polo, I., Mitter, M., Preis, J., Arlt, M., & Gruber, J. (2017) · Scientific Reports · doi:10.1038/srep45197 · Cited by 18 · see citing works
Deciphering synergistic regulatory networks of microRNAs in hESCs and fibroblasts
Sahu, M., & Mallick, B. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.03.061 · Cited by 16 · see citing works
Flagged first, then by citations
2 of the 146 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
NRF2, a Transcription Factor for Stress Response and Beyond
He, F., Ru, X., & Wen, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134777 · Cited by 1,820 · see citing works
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A. E., Crețoiu, D., Suciu, N., Creţoiu, S. M., & Voinea, S. C. (2020) · Cells · doi:10.3390/cells9020276 · Cited by 1,357 · see citing works
Regulatory Mechanism of MicroRNA Expression in Cancer
Syeda, Z. A., Langden, S. S. S., Munkhzul, C., Lee, M., & Song, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051723 · Cited by 1,002 · see citing works
Targeting the progression of chronic kidney disease
Ruiz-Ortega, M., Rayego-Mateos, S., Lamas, S., Ortiz, A., & Rodrigues-Diez, R. R. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0248-y · Cited by 979 · see citing works
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939 · see citing works
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. F., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 895 · see citing works
Deciphering miRNAs’ Action through miRNA Editing
de Sousa, M. C., Gjorgjieva, M., Dolicka, D., Sobolewski, C., & Foti, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246249 · Cited by 823 · see citing works
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 785 · see citing works
Molecular mechanisms of transgenerational epigenetic inheritance
Fitz-James, M. H., & Cavalli, G. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00438-5 · Cited by 589 · see citing works
Targeting circular RNAs as a therapeutic approach: current strategies and challenges
He, A. T., Liu, J., Li, F., & Yang, B. B. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00569-5 · Cited by 556 · see citing works
The Limitless Future of RNA Therapeutics
Damase, T. R., Sukhovershin, R. A., Boada, C., Taraballi, F., Pettigrew, R. I., & Cooke, J. P. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.628137 · Cited by 549 · see citing works
Cisplatin nephrotoxicity: new insights and therapeutic implications
Tang, C., Livingston, M. J., Safirstein, R., & Dong, Z. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00631-7 · Cited by 548 · see citing works
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review
Rascio, F., Spadaccino, F., Rocchetti, M. T., Castellano, G., Stallone, G., Netti, G. S., & Ranieri, E. (2021) · Cancers · doi:10.3390/cancers13163949 · Cited by 497 · see citing works
Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
Tirpe, A., Gulei, D., Ciortea, S. M., Crivii, C. B., & Berindan‐Neagoe, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246140 · Cited by 441 · see citing works
Inflammation and cardiovascular disease: From mechanisms to therapeutics
Alfaddagh, A., Martin, S. S., Leucker, T. M., Michos, E. D., Blaha, M. J., Lowenstein, C. J., Jones, S. R., & Toth, P. P. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100130 · Cited by 473 · see citing works
Advances in multiplexed techniques for the detection and quantification of microRNAs
Jet, T., Gines, G., Rondelez, Y., & Taly, V. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00609b · Cited by 459 · see citing works
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies
Kim, T., & Croce, C. M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01050-9 · Cited by 417 · see citing works
MicroRNA: A signature for cancer progression
Hussen, B. M., Hidayat, H. J., Salihi, A. B., Sabir, D. K., Taheri, M. N., & Ghafouri‐Fard, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111528 · Cited by 407 · see citing works
Regulating IRFs in IFN Driven Disease
Jefferies, C. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00325 · Cited by 364 · see citing works
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381 · see citing works
Polymeric Delivery of Therapeutic Nucleic Acids
Kumar, R., Chalarca, C. F. S., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 370 · see citing works
Chen, S., Tang, Y., Liu, Y., Zhang, P., Lv, L., Zhang, X., Jia, L., & Zhou, Y. (2019) · Cell Proliferation · doi:10.1111/cpr.12669 · Cited by 344 · see citing works
Tomar, M. S., Kumar, A., Srivastava, C., & Shrivastava, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188616 · Cited by 328 · see citing works
Epigenetic regulation by gut microbiota
Woo, V., & Alenghat, T. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2022407 · Cited by 328 · see citing works
Adipogenesis: A Complex Interplay of Multiple Molecular Determinants and Pathways
Ambele, M. A., Dhanraj, P., Giles, R., & Pepper, M. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124283 · Cited by 302 · see citing works
Circulating biomarkers for early detection and clinical management of colorectal cancer
Marcuello, M., Vymetalkova, V. P., Neves, R. P., Durán-Sanchón, S., Vedeld, H. M., Tham, E., van Dalum, G., Flügen, G., García‐Barberán, V., Fijneman, R. J. A., et al. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.06.002 · Cited by 279 · see citing works
Osteoblast Differentiation and Signaling: Established Concepts and Emerging Topics
Ponzetti, M., & Rucci, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136651 · Cited by 285 · see citing works
Molecular mechanisms of environmental exposures and human disease
Wu, H., Eckhardt, C. M., & Baccarelli, A. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00569-3 · Cited by 279 · see citing works
Regulation and Role of Transcription Factors in Osteogenesis
Chan, W. C. W., Tan, Z., To, M. K.-T., & Chan, D. T.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115445 · Cited by 265 · see citing works
A Systematic Review of miR-29 in Cancer
Kwon, J. J., Factora, T. D., Dey, S., & Kota, J. (2018) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2018.12.011 · Cited by 262 · see citing works
miRNA Targets: From Prediction Tools to Experimental Validation
Riolo, G., Cantara, S., Marzocchi, C., & Ricci, C. (2020) · Methods and Protocols · doi:10.3390/mps4010001 · Cited by 242 · see citing works
Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages
Asgarpour, K., Shojaei, Z., Amiri, F., Ai, J., Mahjoubin‐Tehran, M., Ghasemi, F., Arefnezhad, R., Hamblin, M. R., & Mirzaei, H. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00650-6 · Cited by 221 · see citing works
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Talib, W. H., Alsayed, A. R., Barakat, M. M., Abu-Taha, M. I., & Mahmod, A. I. (2021) · Biomedicines · doi:10.3390/biomedicines9101353 · Cited by 268 · see citing works
microRNAs and Their Roles in Plant Development
Dong, Q., Hu, B., & Zhang, C. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.824240 · Cited by 233 · see citing works
Characterizing Extracellular Vesicles and Their Diverse RNA Contents
Veziroglu, E. M., & Mias, G. I. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00700 · Cited by 222 · see citing works
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Bitounis, D., Jacquinet, E., Rogers, M. A., & Amiji, M. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00859-3 · Cited by 237 · see citing works
Nguyen, V. H. L., Hough, R., Bernaudo, S., & Peng, C. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0596-z · Cited by 220 · see citing works
Self-citationVisible-Light-Mediated Modification and Manipulation of Biomacromolecules
Lechner, V. M., Nappi, M., Deneny, P. J., Folliet, S., Chu, J. C. K., & Gaunt, M. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00357 · Cited by 226 · see citing works
Machado, S. A., Pasquarelli-do-Nascimento, G., da Silva, D. S., Farias, G. R., Santos, I. D. O., Baptista, L. B., & Magalhães, K. G. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00694-0 · Cited by 229 · see citing works
Roberts, M. D., McCarthy, J. J., Hornberger, T. A., Phillips, S. M., Mackey, A. L., Nader, G. A., Boppart, M. D., Kavazis, A. N., Reidy, P. T., Ogasawara, R., et al. (2023) · Physiological Reviews · doi:10.1152/physrev.00039.2022 · Cited by 214 · see citing works
Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
Kamal, N. N. S. B. N. M., & Shahidan, W. N. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01500 · Cited by 210 · see citing works
Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
Li, F., Zheng, Z., Chen, W., Li, D., Zhang, H., Zhu, Y., Mo, Q., Zhao, X., Fan, Q., Deng, F., et al. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100938 · Cited by 216 · see citing works
CRISPR‐Cas Biochemistry and CRISPR‐Based Molecular Diagnostics
Weng, Z., You, Z., Yang, J., Mohammad, N., Lin, M., Wei, Q., Gao, X., & Zhang, Y. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202214987 · Cited by 211 · see citing works
miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer’s Patients
Cha, D. J., Mengel, D., Mustapić, M., Liu, W., Selkoe, D. J., Kapogiannis, D., Galasko, D. R., Rissman, R. A., Bennett, D. A., & Walsh, D. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01208 · Cited by 200 · see citing works
miRTargetLink 2.0—interactive miRNA target gene and target pathway networks
Kern, F., Aparicio-Puerta, E., Li, Y., Fehlmann, T., Kehl, T., Wagner, V., Ray, K., Ludwig, N., Lenhof, H.-P., Meese, E., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab297 · Cited by 203 · see citing works
Hyaluronan synthesis and degradation in cartilage and bone
Bastow, E. R., Byers, S., Golub, S. B., Clarkin, C. E., Pitsillides, A. A., & Fosang, A. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7360-z · Cited by 201 · see citing works
LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack
Venkatesh, J., Wasson, M. D., Brown, J. M., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.002 · Cited by 202 · see citing works
Colpaert, R. M. W., & Calore, M. (2019) · Cells · doi:10.3390/cells8070737 · Cited by 198 · see citing works
Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application
Szilágyi, M., Pös, O., Márton, É., Buglyó, G., Soltész, B., Keserű, J. S., Penyige, A., Szemes, T., & Nagy, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186827 · Cited by 193 · see citing works
Yang, Y. M., Cho, Y. E., & Hwang, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020774 · Cited by 203 · see citing works
Panagiotopoulou, O., Wilshin, S. D., Rayfield, E. J., Shefelbine, S. J., & Hutchinson, J. R. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0854 · Cited by 194 · see citing works
RetractedNon-coding RNAs and ferroptosis: potential implications for cancer therapy
Balihodzic, A., Prinz, F., Dengler, M. A., Călin, G. A., Jost, P. J., & Pichler, M. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00998-x · Cited by 170 · see citing works
From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer
Rhim, J., Baek, W., Seo, Y., & Kim, J. H. (2022) · Cells · doi:10.3390/cells11182791 · Cited by 181 · see citing works
Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
Jin, J., Xie, Y., Zhang, J.-S., Wang, J., Dai, S.-J., He, W., Li, S.-Y., Ashby, C. R., Chen, Z., & He, Q. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100929 · Cited by 171 · see citing works
Biogenesis and mechanisms of microRNA‐mediated gene regulation
Rani, V., & Sengar, R. S. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28029 · Cited by 172 · see citing works
Circulating microRNAs as biomarkers in cancer diagnosis
Sohel, M. M. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117473 · Cited by 166 · see citing works
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 166 · see citing works
Calcium Phosphate Nanoparticles for Therapeutic Applications in Bone Regeneration
Levingstone, T. J., Herbaj, S., & Dunne, N. (2019) · Nanomaterials · doi:10.3390/nano9111570 · Cited by 175 · see citing works
Galvão-Lima, L. J., de Morais, A. H. F., Valentim, R. A. D. M., & Barreto, É. J. S. D. S. (2021) · BioMedical Engineering OnLine · doi:10.1186/s12938-021-00857-9 · Cited by 161 · see citing works
Wu, L., Tian, X., Zuo, H., Zheng, W., Li, X., Yuan, M., Tian, X., & Song, H. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01407-8 · Cited by 158 · see citing works
Martino, M. T. D., Arbitrio, M., Caracciolo, D., Cordua, A., Cuomo, O., Grillone, K., Riillo, C., Caridà, G., Scionti, F., Labanca, C., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.005 · Cited by 153 · see citing works
Biomolecular mechanisms of epileptic seizures and epilepsy: a review
Sumadewi, K. T., Harkitasari, S., & Tjandra, D. C. (2023) · Acta Epileptologica · doi:10.1186/s42494-023-00137-0 · Cited by 164 · see citing works
A potential role of microvesicle-containing miR-223/142 in lung inflammation
Zhang, D., Lee, H., Wang, X., Groot, M., Sharma, L., Cruz, C. S. D., & Jin, Y. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212994 · Cited by 155 · see citing works
MicroRNA Involvement in Signaling Pathways During Viral Infection
Barbu, M. G., Condrat, C. E., Thompson, D. C., Bugnar, O. L., Crețoiu, D., Toader, O. D., Suciu, N., & Voinea, S. C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00143 · Cited by 150 · see citing works
Tight junctions: from molecules to gastrointestinal diseases
Moonwiriyakit, A., Pathomthongtaweechai, N., Steinhagen, P., Chantawichitwong, P., Satianrapapong, W., & Pongkorpsakol, P. (2022) · Tissue Barriers · doi:10.1080/21688370.2022.2077620 · Cited by 160 · see citing works
Watson, C. N., Belli, A., & Pietro, V. D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00364 · Cited by 148 · see citing works
Iron homeostasis and organismal aging
Zeidan, R. S., Han, S. M., Leeuwenburgh, C., & Xiao, R. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101510 · Cited by 150 · see citing works
Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles
Razavi, Z. S., Tajiknia, V., Majidi, S., Ghandali, M., Mirzaei, H. R., Rahimian, N., Hamblin, M. R., & Mirzaei, H. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103192 · Cited by 132 · see citing works
Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells
Mierke, C. T. (2024) · Cells · doi:10.3390/cells13010096 · Cited by 146 · see citing works
Lee, S. S., & Cheah, Y. K. (2019) · Journal of Immunology Research · doi:10.1155/2019/3046379 · Cited by 142 · see citing works
Emerging Biomarkers for Early Detection of Chronic Kidney Disease
Mizdrak, M., Kumrić, M., Kurir, T. T., & Božić, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040548 · Cited by 148 · see citing works
Jin, Z. X., Ren, J., & Qi, S. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105946 · Cited by 141 · see citing works
RetractedKukkar, P., Kim, K., Kukkar, D., & Singh, P. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214109 · Cited by 140 · see citing works
Illuminating RNA Biology: Tools for Imaging RNA in Live Mammalian Cells
Braselmann, E., Rathbun, C. M., Richards, E. M., & Palmer, A. E. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.06.010 · Cited by 134 · see citing works
Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Hashemi, F., Moghadam, E. R., Owrang, M., Hashemi, F., Makvandi, P., Goharrizi, M. A. S. B., Najafi, M., et al. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109871 · Cited by 136 · see citing works
Donati, S., Ciuffi, S., & Brandi, M. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184353 · Cited by 139 · see citing works
Mechanisms and biomarkers of cancer-associated thrombosis
Kim, A. S., Khorana, A. A., & McCrae, K. R. (2020) · Translational research · doi:10.1016/j.trsl.2020.06.012 · Cited by 136 · see citing works
Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases
Zhang, T., Yang, Z., Kusumanchi, P., Han, S., & Liangpunsakul, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00007 · Cited by 139 · see citing works
Kalarikkal, S. P., & Sundaram, G. M. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115425 · Cited by 137 · see citing works
DIANA-miTED: a microRNA tissue expression database
Kavakiotis, I., Alexiou, A. T., Tastsoglou, S., Vlachos, I. S., & Hatzigeorgiou, A. G. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab733 · Cited by 114 · see citing works
Small interfering RNA: Discovery, pharmacology and clinical development—An introductory review
Ranasinghe, P., Addison, M. L., Dear, J. W., & Webb, D. J. (2023) · British Journal of Pharmacology · doi:10.1111/bph.15972 · Cited by 138 · see citing works
miRNA profile in ovarian cancer
Ghafouri‐Fard, S., Shoorei, H., & Taheri, M. N. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104381 · Cited by 130 · see citing works
Carbonell, T., & Gomes, A. V. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101607 · Cited by 132 · see citing works
MicroRNAs and Apoptosis in Colorectal Cancer
Wang, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155353 · Cited by 135 · see citing works
The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment
Mosaddeghi-Heris, R., Shirvaliloo, M., Abbaspour‐Aghdam, S., Hazrati, A., Shariati, A., Youshanlouei, H. R., Jadidi‐Niaragh, F., Valizadeh, H., & Ahmadi, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03050-4 · Cited by 123 · see citing works
Khezri, M. R., Jafari, R., Yousefi, K., & Zolbanin, N. M. (2022) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2022.104787 · Cited by 135 · see citing works
Mujtaba, M., Wang, D., Carvalho, L. B., de Oliveira, J. L., Pereira, A. D. E. S., Sharif, R., Jogaiah, S., Paidi, M. K., Wang, L., Ali, Q., et al. (2021) · ACS Agricultural Science & Technology · doi:10.1021/acsagscitech.1c00146 · Cited by 133 · see citing works
Kahroba, H., Ramezani, B., Maadi, H., Sadeghi, M. R., Jaberie, H., & Ramezani, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101211 · Cited by 128 · see citing works
The contribution of epididymosomes to the sperm small RNA profile
Trigg, N. A., Eamens, A. L., & Nixon, B. (2019) · Reproduction · doi:10.1530/rep-18-0480 · Cited by 125 · see citing works
Melas, P. A., Scherma, M., Fratta, W., Cifani, C., & Fadda, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041863 · Cited by 124 · see citing works
GRAND: a database of gene regulatory network models across human conditions
Guebila, M. B., Lopes‐Ramos, C. M., Weighill, D. A., Sonawane, A. R., Burkholz, R., Shamsaei, B., Platig, J., Glass, K., Kuijjer, M. L., & Quackenbush, J. F. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab778 · Cited by 92 · see citing works
The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD
Song, Q., Chen, P., & Liu, X. (2021) · Respiratory Research · doi:10.1186/s12931-021-01630-1 · Cited by 122 · see citing works
Li, H., Zhang, L., & Chen, X. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac358 · Cited by 123 · see citing works
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
Nagasaka, M., Uddin, M. H., Hallak, M. N. A., Rahman, S. B., Balasubramanian, S. K., Sukari, A. W., & Azmi, A. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01371-1 · Cited by 114 · see citing works
Multidrug efflux transporter ABCG2: expression and regulation
Kukal, S., Guin, D., Rawat, C., Bora, S., Mishra, M., Sharma, P., Paul, P. R., Kanojia, N., Grewal, G. K., Kukreti, S., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03901-y · Cited by 119 · see citing works
Pathogenesis of Autoimmune Hepatitis—Cellular and Molecular Mechanisms
Sîrbe, C., Simu, G. R., Szabo, I., Grama, A., & Pop, T. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413578 · Cited by 122 · see citing works
A hybrid CNN-LSTM model for pre-miRNA classification
Taşdelen, A., & Şen, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-93656-0 · Cited by 118 · see citing works
Structural basis of microRNA processing by Dicer-like 1
Wei, X., Ke, H., Wen, A., Gao, B., Shi, J., & Feng, Y. (2021) · Nature Plants · doi:10.1038/s41477-021-01000-1 · Cited by 116 · see citing works
Maity, D., Gupta, U., & Saha, S. (2022) · Nanoscale · doi:10.1039/d2nr03944c · Cited by 118 · see citing works
Regulation of Runx2 by MicroRNAs in osteoblast differentiation
Narayanan, A. M., Srinaath, N., Rohini, M., & Selvamurugan, N. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116676 · Cited by 119 · see citing works
- Authors
- O'Brien, J., Hayder, H., Zayed, Y., & Peng, C.
- Affiliations
- York University (CA)
- Corresponding author
- Peng, Chun
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2018-08-03
- Volume
- 9
- Pages
- 402-402
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC6085463
- OpenAlex
- W2811212358
- Cited by
- 5,287
- References
- 146
- Citations by year
- 2026: 502 · 2025: 781 · 2024: 872 · 2023: 930 · 2022: 906 · 2021: 696 · 2020: 421 · 2019: 149 · 2018: 6 · 2017: 1 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 33.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research (153146_1, MOP89931, 132565_1, 92222_1, MOP-81370)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- microRNA biogenesis, microRNA regulation of gene expression, 3' untranslated region, mRNA degradation, protein synthesis inhibition, Argonaute proteins, exosomes, extracellular miRNAs, intercellular communication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review